Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

Patient-Reported Outcomes Following Fasciotomy for Chronic Exertional Compartment Syndrome.

Maher JM, Brook EM, Chiodo C, Smith J, Bluman EM, Matzkin EG.

Foot Ankle Spec. 2018 Oct;11(5):471-477. doi: 10.1177/1938640018783496. Epub 2018 Jun 22.

PMID:
29931999
2.

Using Genetically Modified Rodent Models in Drug Development to Explore Target Physiology and Potential Drug Effects.

Zhong Y, Dambach DM, Maher JM.

Vet Pathol. 2018 Mar;55(2):193-194. doi: 10.1177/0300985817747328. No abstract available.

PMID:
29457566
3.

A Problem-Sorting Task Detects Changes in Undergraduate Biological Expertise over a Single Semester.

Hoskinson AM, Maher JM, Bekkering C, Ebert-May D.

CBE Life Sci Educ. 2017 Summer;16(2). pii: ar21. doi: 10.1187/cbe.16-05-0175.

4.

Assessing faculty professional development in STEM higher education: Sustainability of outcomes.

Derting TL, Ebert-May D, Henkel TP, Maher JM, Arnold B, Passmore HA.

Sci Adv. 2016 Mar 18;2(3):e1501422. doi: 10.1126/sciadv.1501422. eCollection 2016 Mar.

5.

Identification of a functional antioxidant response element within the eighth intron of the human ABCC3 gene.

Canet MJ, Merrell MD, Harder BG, Maher JM, Wu T, Lickteig AJ, Jackson JP, Zhang DD, Yamamoto M, Cherrington NJ.

Drug Metab Dispos. 2015 Jan;43(1):93-9. doi: 10.1124/dmd.114.060103. Epub 2014 Oct 27.

6.

The other half of the story: effect size analysis in quantitative research.

Maher JM, Markey JC, Ebert-May D.

CBE Life Sci Educ. 2013 Fall;12(3):345-51. doi: 10.1187/cbe.13-04-0082.

7.

Nrf2 in bone marrow-derived cells positively contributes to the advanced stage of atherosclerotic plaque formation.

Harada N, Ito K, Hosoya T, Mimura J, Maruyama A, Noguchi N, Yagami K, Morito N, Takahashi S, Maher JM, Yamamoto M, Itoh K.

Free Radic Biol Med. 2012 Dec 15;53(12):2256-62. doi: 10.1016/j.freeradbiomed.2012.10.001. Epub 2012 Oct 7.

PMID:
23051009
8.

Nrf2 regulates ferroportin 1-mediated iron efflux and counteracts lipopolysaccharide-induced ferroportin 1 mRNA suppression in macrophages.

Harada N, Kanayama M, Maruyama A, Yoshida A, Tazumi K, Hosoya T, Mimura J, Toki T, Maher JM, Yamamoto M, Itoh K.

Arch Biochem Biophys. 2011 Apr 1;508(1):101-9. doi: 10.1016/j.abb.2011.02.001. Epub 2011 Feb 12.

PMID:
21303654
9.

Nrf2-deficiency creates a responsive microenvironment for metastasis to the lung.

Satoh H, Moriguchi T, Taguchi K, Takai J, Maher JM, Suzuki T, Winnard PT Jr, Raman V, Ebina M, Nukiwa T, Yamamoto M.

Carcinogenesis. 2010 Oct;31(10):1833-43. doi: 10.1093/carcin/bgq105. Epub 2010 May 31.

PMID:
20513672
10.

Genetic analysis of cytoprotective functions supported by graded expression of Keap1.

Taguchi K, Maher JM, Suzuki T, Kawatani Y, Motohashi H, Yamamoto M.

Mol Cell Biol. 2010 Jun;30(12):3016-26. doi: 10.1128/MCB.01591-09. Epub 2010 Apr 19.

11.

Nrf2 counteracts cholestatic liver injury via stimulation of hepatic defense systems.

Okada K, Shoda J, Taguchi K, Maher JM, Ishizaki K, Inoue Y, Ohtsuki M, Goto N, Sugimoto H, Utsunomiya H, Oda K, Warabi E, Ishii T, Yamamoto M.

Biochem Biophys Res Commun. 2009 Nov 20;389(3):431-6. doi: 10.1016/j.bbrc.2009.08.156. Epub 2009 Sep 2.

PMID:
19732748
12.

Hepatocyte-specific deletion of heme oxygenase-1 disrupts redox homeostasis in basal and oxidative environments.

Mamiya T, Katsuoka F, Hirayama A, Nakajima O, Kobayashi A, Maher JM, Matsui H, Hyodo I, Yamamoto M, Hosoya T.

Tohoku J Exp Med. 2008 Dec;216(4):331-9.

13.

Nrf2- and PPAR alpha-mediated regulation of hepatic Mrp transporters after exposure to perfluorooctanoic acid and perfluorodecanoic acid.

Maher JM, Aleksunes LM, Dieter MZ, Tanaka Y, Peters JM, Manautou JE, Klaassen CD.

Toxicol Sci. 2008 Dec;106(2):319-28. doi: 10.1093/toxsci/kfn177. Epub 2008 Aug 29.

14.

Ursodeoxycholic acid stimulates Nrf2-mediated hepatocellular transport, detoxification, and antioxidative stress systems in mice.

Okada K, Shoda J, Taguchi K, Maher JM, Ishizaki K, Inoue Y, Ohtsuki M, Goto N, Takeda K, Utsunomiya H, Oda K, Warabi E, Ishii T, Osaka K, Hyodo I, Yamamoto M.

Am J Physiol Gastrointest Liver Physiol. 2008 Oct;295(4):G735-47. doi: 10.1152/ajpgi.90321.2008. Epub 2008 Aug 7.

15.

The Nrf2 activator oltipraz also activates the constitutive androstane receptor.

Merrell MD, Jackson JP, Augustine LM, Fisher CD, Slitt AL, Maher JM, Huang W, Moore DD, Zhang Y, Klaassen CD, Cherrington NJ.

Drug Metab Dispos. 2008 Aug;36(8):1716-21. doi: 10.1124/dmd.108.020867. Epub 2008 May 12.

16.

Ischemia-reperfusion of rat livers decreases liver and increases kidney multidrug resistance associated protein 2 (Mrp2).

Tanaka Y, Chen C, Maher JM, Klaassen CD.

Toxicol Sci. 2008 Jan;101(1):171-8. Epub 2007 Oct 24.

PMID:
17959626
17.

Induction of Mrp3 and Mrp4 transporters during acetaminophen hepatotoxicity is dependent on Nrf2.

Aleksunes LM, Slitt AL, Maher JM, Augustine LM, Goedken MJ, Chan JY, Cherrington NJ, Klaassen CD, Manautou JE.

Toxicol Appl Pharmacol. 2008 Jan 1;226(1):74-83. Epub 2007 Aug 31.

18.

Oxidative and electrophilic stress induces multidrug resistance-associated protein transporters via the nuclear factor-E2-related factor-2 transcriptional pathway.

Maher JM, Dieter MZ, Aleksunes LM, Slitt AL, Guo G, Tanaka Y, Scheffer GL, Chan JY, Manautou JE, Chen Y, Dalton TP, Yamamoto M, Klaassen CD.

Hepatology. 2007 Nov;46(5):1597-610.

PMID:
17668877
19.

Nrf2 and p53 cooperatively protect against BBN-induced urinary bladder carcinogenesis.

Iida K, Itoh K, Maher JM, Kumagai Y, Oyasu R, Mori Y, Shimazui T, Akaza H, Yamamoto M.

Carcinogenesis. 2007 Nov;28(11):2398-403. Epub 2007 Jun 29.

PMID:
17602169
20.

Induction of drug-metabolizing enzymes by garlic and allyl sulfide compounds via activation of constitutive androstane receptor and nuclear factor E2-related factor 2.

Fisher CD, Augustine LM, Maher JM, Nelson DM, Slitt AL, Klaassen CD, Lehman-McKeeman LD, Cherrington NJ.

Drug Metab Dispos. 2007 Jun;35(6):995-1000. Epub 2007 Mar 12.

PMID:
17353348
21.

Nrf2 Neh5 domain is differentially utilized in the transactivation of cytoprotective genes.

Zhang J, Hosoya T, Maruyama A, Nishikawa K, Maher JM, Ohta T, Motohashi H, Fukamizu A, Shibahara S, Itoh K, Yamamoto M.

Biochem J. 2007 Jun 15;404(3):459-66.

22.

Nuclear factor-E2-related factor 2 expression in liver is critical for induction of NAD(P)H:quinone oxidoreductase 1 during cholestasis.

Aleksunes LM, Slitt AL, Maher JM, Dieter MZ, Knight TR, Goedken M, Cherrington NJ, Chan JY, Klaassen CD, Manautou JE.

Cell Stress Chaperones. 2006 Winter;11(4):356-63.

23.
24.

Hepatic ischemia-reperfusion induces renal heme oxygenase-1 via NF-E2-related factor 2 in rats and mice.

Tanaka Y, Maher JM, Chen C, Klaassen CD.

Mol Pharmacol. 2007 Mar;71(3):817-25. Epub 2006 Dec 6.

PMID:
17151289
25.

Regulation of transporter expression in mouse liver, kidney, and intestine during extrahepatic cholestasis.

Slitt AL, Allen K, Morrone J, Aleksunes LM, Chen C, Maher JM, Manautou JE, Cherrington NJ, Klaassen CD.

Biochim Biophys Acta. 2007 Mar;1768(3):637-47. Epub 2006 Oct 26.

26.

BRG1 interacts with Nrf2 to selectively mediate HO-1 induction in response to oxidative stress.

Zhang J, Ohta T, Maruyama A, Hosoya T, Nishikawa K, Maher JM, Shibahara S, Itoh K, Yamamoto M.

Mol Cell Biol. 2006 Nov;26(21):7942-52. Epub 2006 Aug 21.

27.

Kupffer cell-mediated downregulation of hepatic transporter expression in rat hepatic ischemia-reperfusion.

Tanaka Y, Chen C, Maher JM, Klaassen CD.

Transplantation. 2006 Jul 27;82(2):258-66.

PMID:
16858290
28.

Alterations in transporter expression in liver, kidney, and duodenum after targeted disruption of the transcription factor HNF1alpha.

Maher JM, Slitt AL, Callaghan TN, Cheng X, Cheung C, Gonzalez FJ, Klaassen CD.

Biochem Pharmacol. 2006 Aug 14;72(4):512-22. Epub 2006 Mar 30.

PMID:
16806085
29.

Hormonal regulation of renal multidrug resistance-associated proteins 3 and 4 (Mrp3 and Mrp4) in mice.

Maher JM, Cheng X, Tanaka Y, Scheffer GL, Klaassen CD.

Biochem Pharmacol. 2006 May 14;71(10):1470-8. Epub 2006 Mar 9.

PMID:
16529719
30.

Induction of hepatic transporters multidrug resistance-associated proteins (Mrp) 3 and 4 by clofibrate is regulated by peroxisome proliferator-activated receptor alpha.

Moffit JS, Aleksunes LM, Maher JM, Scheffer GL, Klaassen CD, Manautou JE.

J Pharmacol Exp Ther. 2006 May;317(2):537-45. Epub 2006 Feb 8.

PMID:
16467456
31.

Tissue distribution and induction of the rat multidrug resistance-associated proteins 5 and 6.

Maher JM, Cherrington NJ, Slitt AL, Klaassen CD.

Life Sci. 2006 Apr 4;78(19):2219-25. Epub 2005 Nov 2.

PMID:
16260000
32.

Induction of the multidrug resistance-associated protein family of transporters by chemical activators of receptor-mediated pathways in mouse liver.

Maher JM, Cheng X, Slitt AL, Dieter MZ, Klaassen CD.

Drug Metab Dispos. 2005 Jul;33(7):956-62. Epub 2005 Apr 15.

PMID:
15833929
33.

Tissue distribution and hepatic and renal ontogeny of the multidrug resistance-associated protein (Mrp) family in mice.

Maher JM, Slitt AL, Cherrington NJ, Cheng X, Klaassen CD.

Drug Metab Dispos. 2005 Jul;33(7):947-55. Epub 2005 Mar 31.

PMID:
15802388
34.

Expression and regulation of the sterol half-transporter genes ABCG5 and ABCG8 in rats.

Dieter MZ, Maher JM, Cheng X, Klaassen CD.

Comp Biochem Physiol C Toxicol Pharmacol. 2004 Dec;139(4):209-18.

PMID:
15683829
35.

Tissue distribution and hormonal regulation of the breast cancer resistance protein (Bcrp/Abcg2) in rats and mice.

Tanaka Y, Slitt AL, Leazer TM, Maher JM, Klaassen CD.

Biochem Biophys Res Commun. 2005 Jan 7;326(1):181-7.

PMID:
15567169
36.

Induction of multidrug resistance protein 3 (mrp3) in vivo is independent of constitutive androstane receptor.

Cherrington NJ, Slitt AL, Maher JM, Zhang XX, Zhang J, Huang W, Wan YJ, Moore DD, Klaassen CD.

Drug Metab Dispos. 2003 Nov;31(11):1315-9.

PMID:
14570762
37.

Induction of multidrug resistance protein 3 in rat liver is associated with altered vectorial excretion of acetaminophen metabolites.

Slitt AL, Cherrington NJ, Maher JM, Klaassen CD.

Drug Metab Dispos. 2003 Sep;31(9):1176-86.

PMID:
12920174
38.

Jaccoud's arthropathy and inflammatory bowel disease.

Maher JM, Strosberg JM, Rowley RF, Farber M.

J Rheumatol. 1992 Oct;19(10):1637-9.

PMID:
1464881
39.

Clinical outcomes of patients with suspected pulmonary embolism and low-probability aerosol-perfusion scintigrams.

Smith R, Maher JM, Miller RI, Alderson PO.

Radiology. 1987 Sep;164(3):731-3.

PMID:
3303121
40.

Fertility of young mares after long-term anabolic steroid treatment.

Squires EL, Voss JL, Maher JM, Shideler RK.

J Am Vet Med Assoc. 1985 Mar 15;186(6):583-7.

PMID:
3988591
41.

Tension pneumoperitoneum. A cause of acute aortic occlusion.

Olinde AJ, Carpenter D, Maher JM.

Arch Surg. 1983 Nov;118(11):1347-50.

PMID:
6639345
42.

Effect of anabolic steroids on reproductive function of young mares.

Maher JM, Squires EL, Voss JL, Shideler RK.

J Am Vet Med Assoc. 1983 Sep 1;183(5):519-24. No abstract available.

PMID:
6413467
43.

Prediction of solute transport during peritoneal dialysis.

Hirszel P, Lasrich M, Maher JM, Maher JF.

Artif Organs. 1979 Aug;3(3):228-9.

PMID:
394724
44.

Effect of physiological levels of thyroxine on phosphorylation in rat-liver mitochondria.

FAIRHURST AS, MAHER JM, SMITH RE.

Biochim Biophys Acta. 1959 Jan;31(1):296-7. No abstract available.

PMID:
13628651

Supplemental Content

Loading ...
Support Center